YOLFTbeta
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

600332 · SHG · Healthcare / Medical Distribution

19.35CNY-0.12 (-0.62%)

Price History

Full chart

Market Stats

Previous Close19.47
Open19.48
Day Range19.31 – 19.53
52-Week Range19.30 – 27.50
Volume8.15M
Market Cap32.06B
P/E (TTM)12.48
Forward P/E52.91
EPS1.58
Dividend Yield3.80%
Beta0.17
50-Day Avg20.70
200-Day Avg22.79

About

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, production, and sale of health products; and wholesale, retail, and import export of Western medicines, traditional Chinese medicines, and medical devices. The company also offers bio-innovation, consumer health, and medical services; Xiaochaihu granules; Qingkailing and Baoji, Xia Sangju product series; Angong Niuhuang, Zishen Yutai, Xiaoke, Huatuo Zaizao, Zhuangyao Jianshen, and Shujin Jianyao pills; compound Danshen and Naoxinqing tablet series; Banlangen, Compound Banlangen, and Dashen Kouyanqing granules series; and honey-processed Chuanbei and Shedan Chuanbei loquat syrup. In addition, it provides antibacterial and anti-inflammatory drugs, andrological drugs, and analgesics and antipyretics; Wanglaoji herbal tea, Ciningji series, Lixiaoji series, and Yerou coconut milk; and advertising services. Further, the company engages in the medical research industry; technology services industry; leasing and business services; and scientific research and technical services industry. It operates through hospitals, community healthcare facilities, and retail outlets through distributors and agents. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Jiehui Chen
  • Employees26.36K
  • HeadquartersNo. 45, Sha Mian North Street, Guangzhou, China, 510130, China
  • Websitehttps://www.gybys.com.cn

Leadership

  • Mr. Jiehui ChenExecutive Chairman · b. 1976
  • Ms. Liu FeiChief Financial Officer · b. 1977
  • Mr. Hongjin ChengExecutive Director
  • Mr. Heping TangExecutive Director
  • Ms. Xuezhen HuangSecretary · b. 1975
  • Mr. Cheng YuanGM & Executive Deputy Chairman

Financials

Income Statement

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.07B3.38B3.45B4.22B5.33B5.94B6.97B7.71B9.03B10.24B12.32B3.53B3.88B4.49B5.44B12.06B17.61B18.82B19.12B20.04B20.95B42.23B64.95B61.67B69.01B70.79B75.52B74.99B77.45B
Growth (%)-+10.14%+2.09%+22.24%+26.31%+11.43%+17.30%+10.56%+17.10%+13.46%+20.31%-71.37%+10.05%+15.56%+21.26%+121.76%+45.97%+6.87%+1.63%+4.76%+4.58%+101.55%+53.79%-5.05%+11.90%+2.57%+6.68%-0.69%+3.27%
Cost of Revenue2.30B2.57B2.59B3.20B4.16B4.63B5.58B6.31B7.47B8.47B10.25B2.46B2.81B3.21B4.04B8.26B11.84B12.24B12.23B13.44B13.07B32.23B52.76B51.28B55.82B57.55B61.37B62.52B65.69B
Gross Profit776.34M811.74M869.10M1.02B1.17B1.31B1.40B1.40B1.55B1.77B2.07B1.07B1.08B1.28B1.40B3.80B5.77B6.58B6.90B6.60B7.88B10.00B12.19B10.39B13.19B13.24B14.14B12.47B11.76B
Gross Margin25.27%23.99%25.16%24.19%21.94%22.10%20.03%18.11%17.21%17.27%16.79%30.32%27.72%28.54%25.68%31.53%32.78%34.98%36.07%32.94%37.62%23.68%18.77%16.85%19.11%18.70%18.73%16.63%15.18%
Operating Expense630.29M660.17M705.50M821.29M908.54M999.67M1.10B1.22B1.25B1.40B1.59B1.07B1.00B1.10B1.24B3.15B4.65B5.24B5.49B5.13B5.42B6.16B8.14B6.72B8.40B8.17B9.02B8.88B8.66B
Operating Income146.05M151.57M163.60M200.23M261.58M313.71M298.77M178.69M300.25M370.60M482.42M2.20M72.72M179.13M160.53M655.53M1.12B1.34B1.41B1.47B2.46B3.84B4.06B3.67B4.79B5.07B5.12B3.60B3.10B
Operating Margin4.75%4.48%4.74%4.74%4.90%5.28%4.29%2.32%3.33%3.62%3.92%0.06%1.87%3.99%2.95%5.43%6.36%7.13%7.37%7.32%11.74%9.08%6.24%5.95%6.93%7.17%6.78%4.80%4.01%
EBITDA195.21M172.08M164.53M247.12M303.78M413.77M366.62M291.09M427.15M553.59M659.62M309.88M339.74M431.32M444.26M837.40M1.11B1.38B1.39B1.40B2.16B2.68B3.90B3.42B4.39B5.00B5.46B4.07B4.06B
EBITDA Margin6.35%5.09%4.76%5.85%5.70%6.96%5.26%3.78%4.73%5.41%5.35%8.78%8.75%9.61%8.17%6.94%6.31%7.35%7.29%6.99%10.31%6.34%6.01%5.54%6.36%7.07%7.23%5.42%5.24%
Net Income111.53M123.70M128.98M146.23M146.13M158.48M139.80M55.29M184.48M227.33M335.15M182.50M210.99M267.11M287.53M729.04M980.05M1.19B1.30B1.51B2.06B3.44B3.19B2.92B3.72B3.97B4.06B2.84B2.98B
Net Income Margin3.63%3.66%3.73%3.46%2.74%2.67%2.01%0.72%2.04%2.22%2.72%5.17%5.44%5.95%5.29%6.04%5.57%6.35%6.80%7.53%9.84%8.15%4.91%4.73%5.39%5.60%5.37%3.78%3.85%
R&D---9.43M17.62M26.50M35.54M30.98M37.98M36.93M--579.00K71.62M91.13M244.29M282.19M293.50M315.74M330.37M373.29M585.50M576.51M611.93M874.72M819.45M782.14M763.77M607.61M
R&D as % of Total Revenue---0.22%0.33%0.45%0.51%0.40%0.42%0.36%--0.01%1.60%1.68%2.03%1.60%1.56%1.65%1.65%1.78%1.39%0.89%0.99%1.27%1.16%1.04%1.02%0.78%
Interest Expense67.14M43.16M39.89M27.91M7.16M15.33M22.20M47.19M43.10M54.35M67.27M10.21M7.53M1.99M5.82M61.02M47.03M41.31M43.93M20.68M9.71M239.55M426.31M382.63M439.53M453.22M470.09M439.39M427.00M
Interest Expense % of Total Revenue2.19%1.28%1.15%0.66%0.13%0.26%0.32%0.61%0.48%0.53%0.55%0.29%0.19%0.04%0.11%0.51%0.27%0.22%0.23%0.10%0.05%0.57%0.66%0.62%0.64%0.64%0.62%0.59%0.55%

Balance Sheet

Currency: CNY1997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.00B3.00B3.03B3.06B3.70B4.17B4.71B5.18B5.10B5.41B6.21B4.13B4.22B4.48B4.85B6.24B12.25B14.21B15.87B25.90B28.31B51.48B56.89B59.76B66.12B74.67B78.59B81.68B84.51B
Total Liabilities1.70B1.60B1.52B1.57B1.41B1.75B2.11B2.55B2.29B2.46B2.91B905.99M820.92M835.05M956.09M2.01B5.23B6.25B7.19B8.24B9.05B28.34B30.90B31.55B34.79B41.03B41.91B43.91B43.39B
Total Equity1.16B1.26B1.37B1.40B2.17B2.29B2.43B2.44B2.62B2.79B3.06B3.12B3.30B3.54B3.78B4.10B6.83B7.74B8.45B17.35B18.87B21.68B24.18B26.14B29.06B32.07B34.92B35.90B37.79B
Cash654.11M507.63M510.10M488.33M867.41M1.02B816.44M880.82M616.98M489.13M753.17M381.13M696.93M707.40M384.14M729.53M1.94B3.18B4.12B13.09B11.70B16.11B18.47B19.47B22.38B22.50B21.28B18.27B14.94B
Total Debt834.63M696.27M667.75M577.00M442.68M645.02M801.41M1.09B917.79M888.20M956.49M273.28M63.37M38.87M144.93M82.47M518.28M560.53M669.44M58.72M42.81M6.52B6.65B9.56B9.92B11.43B11.70B12.37B20.69B
Net Debt180.52M188.64M157.65M88.67M-424.73M-374.88M-15.03M213.81M300.80M399.07M203.31M-107.86M-633.56M-668.53M-239.21M-647.07M-1.42B-2.62B-3.45B-13.03B-11.65B-9.59B-11.82B-9.91B-12.45B-11.07B-5.48B-5.90B5.75B

Cash Flow

Currency: CNY2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow286.95M140.15M169.01M-6.83M200.54M146.32M38.88M375.74M6.10M439.39M73.17M-180.05M506.53M1.34B1.76B1.94B2.44B1.83B5.22B5.02B585.19M5.67B7.00B4.10B3.44B260.23M
Investing Cash Flow-203.80M-283.59M-167.85M-345.19M-255.87M-118.04M-55.97M-100.69M-224.72M101.16M24.14M-220.53M11.43M-323.70M-287.42M-806.00M-249.16M-2.44B1.11B-1.03B-1.09B-931.57M-7.25B-3.11B-5.96B-3.91B
Financing Cash Flow-102.43M522.41M125.00M150.82M119.78M-291.93M-110.62M-42.64M-248.78K-239.02M-68.32M60.26M-151.55M-211.69M-364.00M-347.45M6.72B-484.27M-2.75B-2.23B1.44B-1.49B45.95M-2.00B-1.01B-100.74M
Capital Expenditure163.53M160.44M173.70M367.18M308.69M124.36M90.45M122.69M126.98M87.56M83.20M58.86M52.61M350.35M353.65M515.34M228.03M196.77M478.62M2.40B876.50M1.25B1.38B1.63B1.13B1.24B
Free Cash Flow123.42M-20.28M-4.68M-374.01M-108.15M21.97M-51.57M253.05M-120.88M351.83M-10.03M-238.92M453.92M988.79M1.41B1.43B2.22B1.64B4.74B2.62B-291.32M4.42B5.62B2.48B2.31B-979.70M
Dividends Paid84.50M6.36M75.60M72.27M85.84M74.55M123.30M136.32M111.44M38.45M42.04M44.54M89.94M36.80M409.85M401.25M512.47M463.64M870.56M689.34M957.59M874.68M1.12B1.19B2.25B1.30B
FCF to OCF43.01%-14.47%-2.77%5475.63%-53.93%15.01%-132.64%67.35%-1980.48%80.07%-13.71%132.69%89.61%73.84%79.92%73.46%90.67%89.27%90.83%52.22%-49.78%77.88%80.23%60.32%67.23%-376.47%
Dividend Paid to FCF68.47%-31.38%-1613.90%-19.32%-79.37%339.39%-239.10%53.87%-92.19%10.93%-418.97%-18.64%19.81%3.72%29.11%28.13%23.12%28.32%18.37%26.28%-328.71%19.80%19.89%48.08%97.25%-132.76%

Earnings

Report DateMar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Oct 30, 2008Mar 29, 2009Jun 3, 2009Aug 30, 2009Nov 3, 2009Mar 28, 2010Jun 2, 2010Aug 27, 2010Nov 2, 2010Mar 25, 2011Apr 28, 2011Aug 26, 2011Nov 1, 2011Feb 16, 2012Apr 26, 2012Aug 24, 2012Oct 29, 2012Feb 28, 2013Aug 30, 2013Oct 30, 2013Mar 17, 2014Apr 28, 2014Aug 29, 2014Oct 29, 2014Mar 19, 2015Apr 28, 2015Aug 14, 2015Oct 30, 2015Mar 18, 2016Apr 27, 2016Aug 17, 2016Oct 25, 2016Mar 15, 2017Apr 26, 2017Aug 20, 2017Oct 22, 2017Mar 15, 2018Apr 26, 2018Aug 22, 2018Oct 29, 2018Mar 17, 2019Apr 28, 2019Aug 22, 2019Oct 28, 2019Mar 31, 2020Apr 28, 2020Aug 25, 2020Oct 28, 2020Mar 18, 2021Apr 28, 2021Aug 18, 2021Oct 26, 2021Mar 18, 2022Apr 26, 2022Aug 19, 2022Oct 25, 2022Mar 17, 2023Apr 27, 2023Aug 18, 2023Oct 30, 2023Jan 26, 2024Apr 26, 2024Aug 30, 2024Oct 25, 2024
EPS Estimate-----------------------0.04-0.07-0.08-0.06-0.08--0.090.09--0.11-0.090.09-0.21-0.270.270.150.200.310.290.190.200.320.320.140.130.270.270.230.310.49-0.010.350.350.480.520.820.060.830.490.420.270.560.390.380.240.650.370.410.100.900.360.550.341.230.550.60
EPS Actual0.060.070.050.010.060.050.050.010.040.060.060.050.050.070.070.060.070.090.100.070.150.140.07-0.030.020.050.090.050.030.080.120.070.050.100.110.070.060.140.120.090.120.340.110.200.240.280.140.210.280.320.140.260.310.330.150.220.300.410.200.300.561.050.510.000.870.700.390.020.740.360.550.161.000.540.500.251.110.480.540.301.170.480.600.161.130.310.32
Surprise------------------------175.00%128.57%-12.50%--50.00%-50.00%--11.11%22.22%--27.27%-0.00%33.33%--47.62%--11.11%3.70%-6.67%5.00%-9.68%10.34%-26.32%30.00%-3.13%3.13%7.14%69.23%11.11%51.85%-13.04%-3.23%14.29%10600.00%45.71%-99.71%81.25%34.62%-52.44%-66.67%-10.84%-26.53%30.95%-40.74%78.57%38.46%31.58%4.17%70.77%29.73%31.71%200.00%30.00%33.33%9.09%-52.94%-8.13%-43.64%-46.67%
Timing-----------------------After-hoursAfter-hours-After-hours-After-hours-After-hours--After-hoursAfter-hours--After-hours-After-hoursAfter-hours-Pre-market-After-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap32.06B
Enterprise Value36.41B
Trailing P/E12.48
Forward P/E52.91
PEG Ratio2.93
Price / Sales0.41
Price / Book0.82
EPS1.58
Book Value24.07
Revenue (TTM)77.91B
Gross Profit (TTM)12.13B
EBITDA3.50B
Profit Margin3.29%
Operating Margin2.18%
Return on Equity6.50%
Return on Assets2.09%
Shares Outstanding1.41B
Shares Float872.95M
Beta0.17
Dividend Yield3.80%
Dividend Rate0.75
Payout Ratio53.94%

Dividends

20231×
0.73Jun 16, 2023
20221×
0.69Jun 17, 2022
20211×
0.54Jun 21, 2021
20201×
0.59Jul 13, 2020
20191×
0.42Jul 11, 2019
20181×
0.38Jul 16, 2018
20171×
0.28Jul 17, 2017
20161×
0.30Nov 28, 2016
20151×
0.28Aug 7, 2015
20142×
0.23Jul 30, 20140.06Jan 23, 2014
20121×
0.10May 18, 2012
20111×
0.05Jul 15, 2011
20101×
0.05Jul 16, 2010
20091×
0.04Jul 17, 2009
20081×
0.12Jun 16, 2008
20071×
0.08Jul 2, 2007
20062×
0.07Jun 30, 20061.64Apr 24, 2006
20051×
0.03Jul 19, 2005
20041×
0.06Jun 25, 2004
20031×
0.06May 30, 2003
20021×
0.06Jun 21, 2002
20011×
0.03Jun 25, 2001